MGEN have Med Gen Inc. exposed to more stock investors 800.940.6559.

Med Gen Inc. Details:

Med Gen, Inc. manufactures and markets specialty products using its proprietary delivery system, Spray’s the Way. Its flagship product includes SNORenz, a throat spray, which reduces or eliminates the sounds ordinarily associated with snoring. The company also provides other products, including Good Nights Sleep, a liquid throat spray formulation for sleep aide; PAINenz, a natural penetrating pain relief roll-on medicine, which formulates to bring temporary relief from minor arthritis, bursitis, muscle aches, backaches, sports related injuries, and sprains muscle strains; and UNDIET, a weight loss program. Med Gen sells its products through DRTV television and print advertising campaigns, as...
May 17, 2008 8:23 AM ET
HEALTH CARE SECTOR
 | 
PHARMACEUTICALS INDUSTRY

Med Gen Inc. (MGEN:OTC BB)

LAST $0.0001 USD
CHANGE TODAY 0.00 0.00%
VOLUME 8.7M
MGEN On Other Exchanges
As of 2:33 PM 05/16/08 All times are local (Market data by Reuters is delayed by at least 15 minutes).
OPEN
$0.0001
PREVIOUS CLOSE
$0.0001
DAY HIGH
$0.0001
DAY LOW
$0.0001
52 WEEK HIGH
05/24/07 - $0.0035
52 WEEK LOW
05/15/08 - $0.0001
MARKET CAP
377.8K
AVERAGE VOLUME 3 mo
13.9M
DILUTED EPS TTM
$-0.03
SHARES OUTSTANDING
3.8B
MGEN Does Not Pay Dividends
P/E TTM
NM
K = Thousands  M = Millions  B = Billions

MGEN Details

Detailed Description...
www.medgen.com
8 Employees
Founded in 1996
  Latest 10-K
  Latest 10-Q
More SEC Filings...

Top Compensated Officers

Mr. Paul B. Kravitz
Chairman, Chief Executive Officer and Secreta...
Age: 75
Total Annual Compensation: $60.8K
Mr. Paul S. Mitchell
President, Chief Operation Officer, Treasurer...
Age: 54
Total Annual Compensation: $60.8K

Executives, Board Directors

Compensation as of Fiscal Year 2007.

Key developments

Med Gen Inc. Receives Approval from CH Laboratories, to Ship Both Snorenz(R) and Painenz(R) into Russia

Med Gen Inc. announced that it has received the approval from its distributor, CH Laboratories, to ship both Snorenz(R) and Painenz(R) into Russia.

Med Gen Inc. Announces Revenue Results for the First Quarter of 2007

Med Gen Inc. announced revenue results for the first quarter of 2007. For the quarter, the company reported unaudited revenue was $512,836 exceeding the same period in 2006 by 195%.

Med Gen Inc. announced delayed annual 10-K filing

On 12/28/2007, Med Gen Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

MGEN, chart, Med Gen Inc.

Stock Quotes

Recently Viewed
MGEN $0.00 USD 0.00

Market data is delayed at least 20 minutes.

Competitors

Company Last Change
No competitor information is available for MGEN.
View Industry Companies
Market data is delayed at least 20 minutes.

Industry Analysis

Valuation MGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

MGEN

Speak with other Med Gen Inc. shareholders.


See popular stocks on our site like MGEN